Interactions between pharmaceutical companies and healthcare professionals (HCPs) and healthcare organizations (HCOs) are indispensable for the exchange of knowledge and the improvement of patient care and are a basic pillar of the pharmaceutical business.

Vifor Pharma is fully committed to ensure that these interactions meet the high standards of integrity expected by patients, governments, the society and other stakeholders. As member of the European Federation of Pharmaceutical Industries and Associations (EFPIA) Vifor Pharma abides by the EFPIA HCP/ HCO Disclosure Code which was adopted to foster transparency and build greater trust among all involved stakeholders.

In accordance with the requirements the EFPIA code and local applicable requirements, Vifor Pharma/ Vifor Fresenius Medical Care Renal Pharma (VFMCRP) disclose on an annual basis for each calendar year Transfers of Value to HCPs and HCOs as well as Transfers of Value arising out of Research and Development (R&D) activities in every EFPIA country where we operate.